263 related articles for article (PubMed ID: 21083037)
1. Follicular lymphoma: emerging therapeutic strategies.
Kenkre VP; Kahl BS
Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic advances for indolent lymphomas].
Ogura M
Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
[TBL] [Abstract][Full Text] [Related]
3. Indolent lymphomas: current and emerging treatment approaches.
Maloney D; Kahl BS; Dreyling M
Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
[TBL] [Abstract][Full Text] [Related]
4. What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma?
Kenkre VP; Kahl BS
Cancer J; 2012; 18(5):383-9. PubMed ID: 23006941
[TBL] [Abstract][Full Text] [Related]
5. Bendamustine's emerging role in the management of lymphoid malignancies.
Rummel MJ; Gregory SA
Semin Hematol; 2011 Apr; 48 Suppl 1():S24-36. PubMed ID: 21530769
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances in therapy of follicular lymphoma].
Liu XX; Wang LN; Yang WL; Xi YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):250-4. PubMed ID: 24598689
[TBL] [Abstract][Full Text] [Related]
7. Current controversies in follicular lymphoma.
Aurora V; Winter JN
Blood Rev; 2006 Jul; 20(4):179-200. PubMed ID: 16410034
[TBL] [Abstract][Full Text] [Related]
8. Biology and treatment of follicular lymphoma.
Piccaluga PP; Sapienza MR; Agostinelli C; Sagramoso C; Mannu C; Sabattini E; Zinzani PL; Pileri SA
Expert Rev Hematol; 2009 Oct; 2(5):533-47. PubMed ID: 21083019
[TBL] [Abstract][Full Text] [Related]
9. Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.
Bachy E; Salles G
Best Pract Res Clin Haematol; 2011 Jun; 24(2):257-70. PubMed ID: 21658622
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma.
Laport GG
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):59-65. PubMed ID: 16399587
[TBL] [Abstract][Full Text] [Related]
12. Current immunochemotherapy strategies in follicular lymphoma.
Giné E; Gutiérrez-García G; López-Guillermo A
Adv Ther; 2010 Oct; 27(10):704-13. PubMed ID: 20820973
[TBL] [Abstract][Full Text] [Related]
13. Rituximab maintenance versus retreatment in follicular lymphoma.
Palla AR; Hamadani M
Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
[TBL] [Abstract][Full Text] [Related]
14. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
Cohen Y; Solal-Céligny P; Polliack A
Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
[TBL] [Abstract][Full Text] [Related]
15. SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
Zinzani PL; Marchetti M; Billio A; Barosi G; Carella AM; Lazzarino M; Martelli M; Rambaldi A; Rigacci L; Tarella C; Vitolo U; Tura S;
Am J Hematol; 2013 Mar; 88(3):185-92. PubMed ID: 23339086
[TBL] [Abstract][Full Text] [Related]
16. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
Oliansky DM; Gordon LI; King J; Laport G; Leonard JP; McLaughlin P; Soiffer RJ; van Besien KW; Werner M; Jones RB; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2010 Apr; 16(4):443-68. PubMed ID: 20114084
[TBL] [Abstract][Full Text] [Related]
17. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Naparstek E
Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in autologous stem cell transplantation for follicular lymphoma.
Schmitz N
Anticancer Drugs; 2001 Jun; 12 Suppl 2():S21-4. PubMed ID: 11508933
[TBL] [Abstract][Full Text] [Related]
19. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M
Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021
[No Abstract] [Full Text] [Related]
20. New agents in follicular lymphoma.
Cheson BD
Best Pract Res Clin Haematol; 2011 Jun; 24(2):305-12. PubMed ID: 21658626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
